A detailed history of Royal Bank Of Canada transactions in Mannkind Corp stock. As of the latest transaction made, Royal Bank Of Canada holds 302,427 shares of MNKD stock, worth $2.12 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
302,427
Previous 156,891 92.76%
Holding current value
$2.12 Million
Previous $818,000 132.15%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$5.01 - $6.7 $729,135 - $975,091
145,536 Added 92.76%
302,427 $1.9 Million
Q2 2024

Aug 14, 2024

BUY
$4.05 - $5.43 $176,256 - $236,313
43,520 Added 38.39%
156,891 $818,000
Q1 2024

Nov 05, 2024

SELL
$3.25 - $5.27 $141,440 - $229,350
-43,520 Reduced 27.74%
113,371 $513,000
Q1 2024

May 15, 2024

SELL
$3.25 - $5.27 $237,734 - $385,495
-73,149 Reduced 39.22%
113,371 $513,000
Q4 2023

Feb 14, 2024

BUY
$3.34 - $4.29 $175,650 - $225,611
52,590 Added 39.27%
186,520 $678,000
Q3 2023

Nov 14, 2023

SELL
$3.91 - $5.45 $692,941 - $965,865
-177,223 Reduced 56.96%
133,930 $553,000
Q2 2023

Aug 14, 2023

SELL
$3.72 - $4.79 $42,225 - $54,371
-11,351 Reduced 3.52%
311,153 $1.27 Million
Q1 2023

May 15, 2023

BUY
$3.95 - $5.63 $451,437 - $643,441
114,288 Added 54.89%
322,504 $1.32 Million
Q4 2022

Feb 14, 2023

BUY
$3.02 - $5.37 $116,354 - $206,895
38,528 Added 22.71%
208,216 $1.1 Million
Q3 2022

Nov 14, 2022

BUY
$2.99 - $4.35 $58,783 - $85,521
19,660 Added 13.1%
169,688 $524,000
Q2 2022

Aug 15, 2022

SELL
$2.67 - $4.77 $28,755 - $51,372
-10,770 Reduced 6.7%
150,028 $571,000
Q1 2022

May 16, 2022

SELL
$2.62 - $4.45 $497,116 - $844,338
-189,739 Reduced 54.13%
160,798 $591,000
Q4 2021

Feb 14, 2022

BUY
$4.05 - $5.37 $878,611 - $1.16 Million
216,941 Added 162.39%
350,537 $1.53 Million
Q3 2021

Nov 15, 2021

BUY
$3.89 - $5.48 $68,518 - $96,524
17,614 Added 15.19%
133,596 $580,000
Q2 2021

Aug 16, 2021

BUY
$3.61 - $5.45 $418,695 - $632,101
115,982 New
115,982 $633,000

Others Institutions Holding MNKD

About MANNKIND CORP


  • Ticker MNKD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 257,338,000
  • Market Cap $1.81B
  • Description
  • MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...
More about MNKD
Track This Portfolio

Track Royal Bank Of Canada Portfolio

Follow Royal Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.